Article info
PDFCardiac risk factors and prevention
Original research
Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease
- Correspondence to Mr Einar Smith, Department of Clinical Sciences, Lund University, Malmö 21428, Sweden; einar.smith{at}med.lu.se
Citation
Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease
Publication history
- Received May 29, 2019
- Revised September 19, 2019
- Accepted October 1, 2019
- First published October 31, 2019.
Online issue publication
April 14, 2020
Article Versions
- Previous version (31 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.